3-117224163-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000717962.1(LSAMP):n.593+115567A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.428 in 152,084 control chromosomes in the GnomAD database, including 14,763 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.43 ( 14763 hom., cov: 32)
Consequence
LSAMP
ENST00000717962.1 intron
ENST00000717962.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.65
Publications
6 publications found
Genes affected
LSAMP (HGNC:6705): (limbic system associated membrane protein) This gene encodes a member of the immunoglobulin LAMP, OBCAM and neurotrimin (IgLON) family of proteins. The encoded preproprotein is proteolytically processed to generate a neuronal surface glycoprotein. This protein may act as a selective homophilic adhesion molecule during axon guidance and neuronal growth in the developing limbic system. The encoded protein may also function as a tumor suppressor and may play a role in neuropsychiatric disorders. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.691 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| LOC124909415 | XR_007096015.1 | n.29329+24853A>G | intron_variant | Intron 1 of 1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LSAMP | ENST00000717962.1 | n.593+115567A>G | intron_variant | Intron 3 of 6 |
Frequencies
GnomAD3 genomes AF: 0.428 AC: 65075AN: 151966Hom.: 14736 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
65075
AN:
151966
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.428 AC: 65147AN: 152084Hom.: 14763 Cov.: 32 AF XY: 0.428 AC XY: 31793AN XY: 74362 show subpopulations
GnomAD4 genome
AF:
AC:
65147
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
31793
AN XY:
74362
show subpopulations
African (AFR)
AF:
AC:
22360
AN:
41450
American (AMR)
AF:
AC:
7228
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1660
AN:
3468
East Asian (EAS)
AF:
AC:
3667
AN:
5162
South Asian (SAS)
AF:
AC:
2085
AN:
4828
European-Finnish (FIN)
AF:
AC:
3024
AN:
10584
Middle Eastern (MID)
AF:
AC:
153
AN:
294
European-Non Finnish (NFE)
AF:
AC:
23704
AN:
67996
Other (OTH)
AF:
AC:
952
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1850
3700
5549
7399
9249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1920
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.